Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Harbour BioMed Announces Dosing of First Patient in Tanfanercept Phase III Clinical Trial

prnasiaMarch 12, 2021

Tag: Harbour , Tanfanercept , DED

PharmaSources Customer Service